Humatrope Kit
Product Images NDC 0002-8147

Product Visual Gallery

This gallery contains 100 technical images submitted to the FDA as part of the official labeling for Humatrope (NDC 0002-8147). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Eli Lilly And Company, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Htr Cart 1 V1

An instructional diagram of the HUMATROPE kit components by Eli Lilly and Company. It shows a diluent syringe labeled with a plunger, diluent, and needle cover. Next to it is the Humatrope cartridge with black triangles, expiration date, and white tip. The diagram also includes an end cap illustration.*

FDA Label Image

Htr Cart 10 V1

An instructional illustration showing a hand holding a Lilly-branded pen injector device vertically above a circular button or base, with a downward-pointing arrow indicating the device should be pressed or positioned down onto the surface.*

FDA Label Image

Htr Cart 11 V1

A black and white instructional diagram showing a hand holding a HUMATROPE injection device. The illustration demonstrates rotating the device 10 times as indicated by a curved arrow and the number 'x 10.' This likely represents a step in preparing the device for use.*

FDA Label Image

Htr Cart 12 V1

The image shows a clear single-use syringe containing a liquid medication, part of the HUMATROPE (Somatropin) kit for intramuscular or subcutaneous injection, labeled by Eli Lilly and Company. The syringe has a transparent barrel and a plunger with visible markings.*

FDA Label Image

Htr Cart 2 V1

Instructional illustration showing a HUMATROPE kit by Eli Lilly and Company, featuring a syringe with a Lilly label and vial for intramuscular or subcutaneous injection. A hand is depicted placing or removing the vial, with an inset showing hand washing, indicating preparation steps prior to use.*

FDA Label Image

Htr Cart 3 V1

An instructional diagram showing a hand holding a syringe labeled 'Lilly,' with annotations pointing to the plunger at the top and the needle cover at the bottom. The illustration demonstrates how to hold the syringe, likely related to administering HUMATROPE (somatropin) injection.*

FDA Label Image

Htr Cart 4 V1

An instructional illustration showing hands holding a HUMATROPE injection pen. The top panel highlights the plunger labeled with Eli Lilly, while the bottom panel shows the needle cover being removed with a downward arrow indicating the action.*

FDA Label Image

Htr Cart 5 V1

An instructional illustration showing proper handling of a HUMATROPE injection device, highlighting the correct positioning of the device with visible black triangles and cautioning against an incorrect grip indicated by a red prohibition symbol.*

FDA Label Image

Htr Cart 6 V1

An instructional illustration showing a person holding a syringe-like device labeled with 'Lilly'. The illustration depicts the action of removing a needle cap using both hands, indicated by a black upward arrow.*

FDA Label Image

Htr Cart 7 V1

Illustration showing a hand holding a syringe labeled with 'Lilly.' The diagram highlights the plunger of the syringe, depicting downward arrows indicating the plunger being pressed. This instructional image appears to demonstrate the action of pushing the syringe plunger, likely related to the HUMATROPE injection kit use.*

FDA Label Image

Htr Cart 8 V1

An instructional illustration showing a hand holding a syringe with the label 'Lilly' on it, demonstrating the action of rotating or twisting a part of the syringe with the thumb. This likely depicts a step in preparing or using the injection device for HUMATROPE, a somatropin kit by Eli Lilly and Company.*

FDA Label Image

Htr Cart 9 V1

An instructional illustration showing two hands preparing a HUMATROPE injection device by Eli Lilly and Company, demonstrating how to connect or align the syringe and pen components for intramuscular or subcutaneous administration.*

FDA Label Image

Htr Hnc 1 V1

Packaging label of HUMATROPE kit by Eli Lilly and Company, containing Somatropin. The label features a predominantly white background with a green bottom edge and a yellow cap. The brand name "Lilly" is visible in cursive on the label, along with yellow and green design elements.*

FDA Label Image

Htr Hnc 2 V1

An instructional diagram showing the mechanism of a sliding lock on a cylindrical device, labeled with parts such as Guide Channel, Guide Post, Slider, and Body. The diagram includes two smaller insets demonstrating the Locked and Unlocked positions of the Slider relative to the Body.*

FDA Label Image

Htr Hnc 3 V1

An instructional illustration showing a hand holding a syringe with a red arrow indicating the action of removing a cap or protective cover from the syringe. The image suggests preparation steps for an intramuscular or subcutaneous injection, relevant to the HUMATROPE kit containing somatropin.*

FDA Label Image

Htr Hnc 4 V1

An instructional illustration showing a close-up of a hand holding a device with the Lilly logo, demonstrating the removal of a red cap from the end of the device. This likely pertains to a step in preparing or using the Humatrope kit for intramuscular or subcutaneous administration.*

FDA Label Image

Htr Hnc 5 V1

Instructional illustration showing a hand holding a syringe and pressing a plunger to inject medication. The image likely demonstrates how to administer the drug HUMATROPE (Somatropin) via intramuscular or subcutaneous injection.*

FDA Label Image

Htr Hnc 6 V1

A close-up image showing a dial on a medical device or injector, with a numeric display reading '0.00'. This likely represents dosage measurement for a medication delivery device.*

FDA Label Image

Htr Hnc Locked V1

An instructional diagram showing how to connect or use components of the HUMATROPE injection kit by Eli Lilly and Company. The image features a yellow shaded area with line drawings illustrating the attachment of parts, likely representing the preparation steps for administration via intramuscular or subcutaneous injection.*

FDA Label Image

Htr Hnc Unlocked V1

An illustration showing the assembly or use of a device with components numbered 1 and 2. The diagram includes an arrow pointing to a specific area labeled with a lock icon, indicating a locking or unlocking mechanism, possibly for a pen or injector device related to HUMATROPE (Somatropin) kit.*

FDA Label Image

Htr Ifu 12mg 1 V1

HUMATROPE 12 mg Somatropin injection pen, a human prescription drug KIT designed for intramuscular and subcutaneous administration. The image shows a green and white injection pen with dosage markings and the Eli Lilly and Company logo on the pen.*

FDA Label Image

Htr Ifu 12mg 10 V1

Illustration showing a close-up of hands preparing a HUMATROPE (somatropin) injection. One hand holds a vial labeled HUMATROPE 12 mg, while the other hand is removing the cap from a syringe or needle, indicated by a red arrow pointing away from the vial.*

FDA Label Image

Htr Ifu 12mg 11 V1

An instructional illustration showing a close-up of a hand adjusting the dose indicator on a HUMATROPE (somatropin) injection pen. The pen dial displays measurement markings for the drug dose in milligrams or units, with a red arrow pointing to the selected dose. The illustration highlights dose setting for intramuscular or subcutaneous administration.*

FDA Label Image

Htr Ifu 12mg 12 V1

An instructional illustration showing the preparation of an injection using a Humatrope kit. The image depicts a hand holding a syringe-like device, attaching it to a vial, with arrows indicating the direction for mixing or drawing the medication. A close-up inset highlights a needle drawing solution from a vial labeled Humatrope.*

FDA Label Image

Htr Ifu 12mg 13 V1

An instructional illustration showing a hand holding a capped syringe with the label HUMATROPE, and another hand removing the cap in preparation for injection. The scene suggests step-by-step preparation of the HUMATROPE kit for intramuscular or subcutaneous administration.*

FDA Label Image

Htr Ifu 12mg 14 V1

Illustration showing a hand holding a HUMATROPE Somatropin injection pen, designed for intramuscular or subcutaneous use. The labeled pen displays a dose indicator set to 12 mg, and part of the Lilly logo is visible on the yellow pen body.*

FDA Label Image

Htr Ifu 12mg 15 V1

An instructional illustration depicting a hand removing a red protective cap from a Humatrope 12 mg somatropin injection pen. The image highlights preparation steps for intramuscular or subcutaneous administration of the human prescription drug kit by Eli Lilly and Company.*

FDA Label Image

Htr Ifu 12mg 16 V1

An illustration showing a close-up of a person adjusting a dose on a Lilly-branded injection pen, indicating the setting of 0.50 units. The red arrow points to the dosing dial, demonstrating how to turn the dial for dose selection, related to administration of HUMATROPE (Somatropin) via intramuscular or subcutaneous injection.*

FDA Label Image

Htr Ifu 12mg 17 V1

An instructional illustration showing the proper use of an injection device. The image depicts a hand holding a syringe and an insulin pen or similar device with an arrow indicating to press or hold the button. A clock icon with "5 seconds" text instructs the user to hold the injection for 5 seconds before removing.*

FDA Label Image

Htr Ifu 12mg 18 V1

An illustration showing a close-up of a dosage dial on a device, set to a dose of 0.00. The dial appears to be part of an injection device, possibly for precise medication measurement, relevant to HUMATROPE (Somatropin) administration.*

FDA Label Image

Htr Ifu 12mg 19 V1

An instructional illustration showing a hand holding a HUMATROPE (Somatropin) injection pen with a red arrow indicating the removal of the protective cap from the needle prior to administration. This diagram visually guides the step of preparing the injection device for use.*

FDA Label Image

Htr Ifu 12mg 2 V1

An illustrated diagram of the HUMATROPE 12 mg cartridge kit showing the individual components labeled: pen cap, rubber seal, white tip, 12 mg cartridge, screw, front housing, 12 mg pen body, dose window, dose knob, and injection button. The kit is for intramuscular and subcutaneous use and manufactured by Eli Lilly and Company.*

FDA Label Image

Htr Ifu 12mg 20 V1

An instructional illustration showing hands holding a HUMATROPE (somatropin) 12 mg injection pen. The image depicts the process of preparing the injection, emphasizing grip and positioning of the pen's parts before administration.*

FDA Label Image

Htr Ifu 12mg 21 V1

An instructional illustration showing a hand holding a syringe-like device labeled HUMATROPE, with an arrow indicating the removal of a protective cap from the device.*

FDA Label Image

Htr Ifu 12mg 3 V1

An instructional illustration showing a hand holding a Humatrope kit, a human prescription drug containing Somatropin. The image highlights the preparation and usage of the injectable kit for intramuscular or subcutaneous administration, labeled by Eli Lilly and Company.*

FDA Label Image

Htr Ifu 12mg 4 V1

Illustration shows a hand holding a prefilled syringe for HUMATROPE (somatropin) and points to the location of the expiration date on the syringe label. The illustration emphasizes proper identification of the expiration date on the medication device.*

FDA Label Image

Htr Ifu 12mg 5 V1

An instructional illustration showing a hand removing a protective cap from a yellow injection device, held by the other hand, as indicated by a red arrow pointing left. It depicts a preparation step for administering an injection, relevant for HUMATROPE somatropin kit usage.*

FDA Label Image

Htr Ifu 12mg 6 V1

HUMATROPE 12 mg kit for injection by Eli Lilly and Company shown with close-up views of the pen's dosage dial and the injectable solution inside a cartridge labeled Somatropin for intramuscular or subcutaneous use.*

FDA Label Image

Htr Ifu 12mg 7 V1

An instructional diagram showing two device components labeled 'White Tip' and 'Screw', with an arrow indicating connection or assembly between them. The image appears related to the HUMATROPE Somatropin injection kit.*

FDA Label Image

Htr Ifu 12mg 8 V1

An instructional illustration showing hands peeling back a red tamper-evident seal from a HUMATROPE 12 mg injection pen. The image demonstrates the initial step in preparing the HUMATROPE kit, which contains Somatropin for intramuscular or subcutaneous injection. The pen is labeled with the brand name and dosage.*

FDA Label Image

Htr Ifu 12mg 9 V1

An instructional illustration showing the proper connection of a needle to the Humatrope 12 mg kit pen device. The image features a hand attaching the needle to the pen, indicating the preparation step for subcutaneous or intramuscular administration of Humatrope (somatropin).*

FDA Label Image

Htr Ifu 24mg 1 V1

HUMATROPE 2.4 mg Somatropin kit pen for intramuscular or subcutaneous use by Eli Lilly and Company. The image shows the pen device with a label displaying the dosage strength and product name, including a visible dose window and a green and white design.*

FDA Label Image

Htr Ifu 24mg 10 V1

An instructional illustration showing the removal of the protective cap from a HUMATROPE 2.4 mg Somatropin injection pen prior to use. The image depicts hands holding the pen and cap, with an arrow indicating the direction to pull the cap off.*

FDA Label Image

Htr Ifu 24mg 11 V1

An instructional illustration depicting how to use the HUMATROPE kit by Eli Lilly and Company. The image shows a hand adjusting a dosage dial on the green device, with visible dosage markings and an arrow indicating the direction to increase the dose for administering somatropin intramuscularly or subcutaneously.*

FDA Label Image

Htr Ifu 24mg 12 V1

An instructional illustration showing a person preparing a HUMATROPE kit for use. The image highlights the connection of the vial to the device and the process of drawing liquid into the syringe for intramuscular or subcutaneous injection.*

FDA Label Image

Htr Ifu 24mg 13 V1

An instructional illustration showing hands preparing a HUMATROPE (Somatropin) injection pen. The image depicts someone removing a protective cap from the needle while holding the injection pen, indicating a step in preparing the medication for intramuscular or subcutaneous administration.*

FDA Label Image

Htr Ifu 24mg 14 V1

An illustrated image showing a hand holding a HUMATROPE injection pen. The pen is green and white, labeled with the brand name HUMATROPE and dosage information, designed for intramuscular or subcutaneous administration of somatropin.*

FDA Label Image

Htr Ifu 24mg 15 V1

An instructional illustration showing a hand removing a cap from a Humatrope (Somatropin) injection pen or syringe. The image highlights the preparation step for subcutaneous or intramuscular administration of the drug, labeled with the dosage strength of 24 mg.*

FDA Label Image

Htr Ifu 24mg 16 V1

An instructional illustration showing a person's hand adjusting a dose selector on a HUMATROPE injection pen. The dose indicator window displays a numeric value, and a large red arrow points upwards, indicating how to turn or set the dose on the pen device for intramuscular or subcutaneous injection.*

FDA Label Image

Htr Ifu 24mg 17 V1

Instructional diagram showing administration of HUMATROPE (Somatropin) using a syringe or pen device. A hand holds the device with a thumb pressing at the plunger while the other hand holds the injection site. A clock icon and text '5 seconds' indicate the time to hold the injection in place for proper delivery via intramuscular or subcutaneous route.*

FDA Label Image

Htr Ifu 24mg 18 V1

Illustration showing a close-up view of a dose indicator on a Humatrope injection pen, featuring a numeric display reading '0.00.' This image relates to the Somatropin medication delivered via an intramuscular or subcutaneous route.*

FDA Label Image

Htr Ifu 24mg 19 V1

An illustration showing a hand holding a HUMATROPE injection syringe labeled with dosage markings and product details. The image demonstrates removing the protective cap from the needle prior to administration using the intramuscular or subcutaneous route.*

FDA Label Image

Htr Ifu 24mg 2 V1

An instructional diagram showing parts of the HUMATROPE kit, including the pen cap, 24 mg cartridge, rubber seal, white tip, screw, front housing, 24 mg pen body with dose window, dose knob, and injection button. The components are labeled and separated for clarity.*

FDA Label Image

Htr Ifu 24mg 20 V1

An instructional illustration showing hands preparing a Humatrope (somatropin) injection pen. The label on the pen displays '24 mg Humatrope (somatropin) for injection' along with an NDC number and lot code. The image highlights the dose setting or injection preparation step.*

FDA Label Image

Htr Ifu 24mg 21 V1

Instructional illustration showing the steps to prepare a HUMATROPE (Somatropin) injection kit for use. A hand is depicted removing a protective cap from a syringe or needle assembly. The image suggests preparation for intramuscular or subcutaneous administration of the drug.*

FDA Label Image

Htr Ifu 24mg 3 V1

An illustration showing a hand holding a HUMATROPE (somatropin) kit, displaying the drug label on a syringe or cartridge indicating 24 mg strength. The kit is for intramuscular or subcutaneous administration, produced by Eli Lilly and Company.*

FDA Label Image

Htr Ifu 24mg 4 V1

An instructional illustration showing a hand holding a syringe or pen injector labeled with an 'Expiration Date' indicator, demonstrating where to locate the expiration date on the device. The image relates to the HUMATROPE somatropin kit, highlighting proper identification of expiration date on the dosing device.*

FDA Label Image

Htr Ifu 24mg 5 V1

An instructional illustration showing a hand holding a HUMATROPE injection pen and another hand removing or preparing a cap by pulling it off as indicated by a red arrow. The image demonstrates part of the preparation process for administering HUMATROPE (Somatropin) via intramuscular or subcutaneous injection.*

FDA Label Image

Htr Ifu 24mg 6 V1

HUMATROPE 24 mg kit label for Somatropin injection. The label includes the strength 24 mg and the proprietary name HUMATROPE with the generic name Somatropin. The product is manufactured by Eli Lilly and Company for intramuscular or subcutaneous use.*

FDA Label Image

Htr Ifu 24mg 7 V1

An instructional diagram showing a white tip component and a green screw component, indicating a connection or assembly step between the two parts, likely related to the HUMATROPE somatropin kit.*

FDA Label Image

Htr Ifu 24mg 8 V1

An instructional illustration showing two hands handling a HUMATROPE Somatropin injection pen, highlighting the steps to prepare or administer the medication by turning or twisting parts of the pen device before use. The image emphasizes proper usage of the intramuscular or subcutaneous kit form by Eli Lilly and Company.*

FDA Label Image

Htr Ifu 24mg 9 V1

An instructional illustration showing a hand removing a protective cap from a HUMATROPE 24 mg Somatropin cartridge, part of a kit for intramuscular or subcutaneous administration. The cartridge is labeled with the product name, strength, and is manufactured by Eli Lilly and Company.*

FDA Label Image

Htr Ifu 6mg 1 V1

HUMATROPE 6 mg kit containing Somatropin for intramuscular or subcutaneous use by Eli Lilly and Company. The image shows the product in a pen device with a label indicating the 6 mg strength and brand name, designed for human prescription drug use.*

FDA Label Image

Htr Ifu 6mg 10 V1

Instructional diagram for HUMATROPE somatropin kit showing the removal of the needle cap from a vial prior to injection. The vial is labeled with HUMATROPE 4 mg, intended for intramuscular or subcutaneous administration. The image focuses on preparation steps for use.*

FDA Label Image

Htr Ifu 6mg 11 V1

An instructional illustration showing a close-up view of a dosing syringe labeled with measurement marks from 0.05 to 1.25, with a person's hand adjusting a red arrow indicator on the syringe to select a specific dose. The syringe is associated with HUMATROPE (Somatropin) for intramuscular or subcutaneous administration.*

FDA Label Image

Htr Ifu 6mg 12 V1

An instructional illustration showing hands holding a HUMATROPE injection device, with a close-up focus on the syringe needle. The diagram highlights the preparation or administration process for intramuscular or subcutaneous injection, related to the HUMATROPE Somatropin kit by Eli Lilly and Company.*

FDA Label Image

Htr Ifu 6mg 13 V1

An instructional illustration showing hands preparing a HUMATROPE (somatropin) injection device. One hand removes the protective cap from the syringe, indicated by a red arrow, demonstrating a step for intramuscular or subcutaneous administration.*

FDA Label Image

Htr Ifu 6mg 14 V1

An illustration of a hand holding a HUMATROPE (somatropin) injection pen showing the dosage window labeled 4 mg. The pen is designed for intramuscular or subcutaneous administration, consistent with the product's use as a human prescription drug by Eli Lilly and Company.*

FDA Label Image

Htr Ifu 6mg 15 V1

An instructional illustration showing a hand removing the cap from a Humatrope cartridge, labeled 6 mg. The image demonstrates preparation for intramuscular or subcutaneous injection of Humatrope (Somatropin), a human prescription drug kit by Eli Lilly and Company.*

FDA Label Image

Htr Ifu 6mg 16 V1

An instructional illustration showing a close-up of a hand adjusting a dial on a HUMATROPE (Somatropin) injection pen. The dial displays dosage increments, including 0.25, with a red arrow indicating the direction to turn the dial for dose setting.*

FDA Label Image

Htr Ifu 6mg 17 V1

An instructional diagram showing a hand administering a subcutaneous injection with an insulin-type syringe and vial. The image includes an arrow indicating a push motion on the vial, a clock symbol with '5 seconds' suggesting injection duration, and a second hand stabilizing the injection site. The illustration is related to the administration of HUMATROPE (Somatropin) via intramuscular or subcutaneous route.*

FDA Label Image

Htr Ifu 6mg 18 V1

An instructional close-up image showing a dosage adjustment dial on a HUMATROPE kit, designed for intramuscular or subcutaneous administration. The dial display includes markings starting at 0.00, indicating precision dose setting for the human prescription drug Somatropin by Eli Lilly and Company.*

FDA Label Image

Htr Ifu 6mg 19 V1

An instructional illustration showing a hand holding a HUMATROPE kit, with the needle cap being removed and an arrow indicating the direction of removal. The image demonstrates the preparation step for using the Somatropin injection kit.*

FDA Label Image

Htr Ifu 6mg 2 V1

An illustration showing the parts of the HUMATROPE pen needle and pen body kit for somatropin delivery. It includes a pen cap, a 6 mg cartridge with rubber seal and white tip (sold separately), a screw connecting to the front housing, a 6 mg pen body with dose window and dose knob, and an injection button. Pen needles are not included.*

FDA Label Image

Htr Ifu 6mg 20 V1

Illustration showing a HUMATROPE (somatropin) 6 mg injection kit being prepared for use. The image depicts hands holding the syringe and vial with a red arrow indicating the connection or mixing step prior to intramuscular or subcutaneous administration.*

FDA Label Image

Htr Ifu 6mg 21 V1

An instructional illustration showing how to remove the cap from a HUMATROPE (somatropin) injection pen prior to administration. The image depicts hands holding the pen and removing the protective cover with an arrow indicating the direction of removal.*

FDA Label Image

Htr Ifu 6mg 3 V1

Illustration showing a hand holding a prefilled syringe, likely demonstrating how to hold or prepare the HUMATROPE (somatropin) injection kit for intramuscular or subcutaneous administration.*

FDA Label Image

Htr Ifu 6mg 4 V1

An instructional illustration showing a hand holding a vial or cartridge labeled with an expiration date, indicating where to find the expiration date on the product. This relates to the HUMATROPE Somatropin kit, used for intramuscular or subcutaneous administration.*

FDA Label Image

Htr Ifu 6mg 5 V1

Illustration showing two hands preparing a HUMATROPE (Somatropin) injection kit. One hand is holding the needle cap with an arrow indicating removal, and the other hand is holding the injection device, demonstrating stepwise assembly or preparation for intramuscular or subcutaneous administration.*

FDA Label Image

Htr Ifu 6mg 6 V1

HUMATROPE 6 mg kit label for somatropin for injection, showing the vial with a white and yellow cap, the product name HUMATROPE® and strength 6 mg clearly visible on the vial label. The packaging is designed for intramuscular and subcutaneous administration, manufactured by Eli Lilly and Company.*

FDA Label Image

Htr Ifu 6mg 7 V1

An instructional illustration showing the connection of the white tip of a HUMATROPE injection cartridge to the screw mechanism of a delivery pen, indicating how to attach the cartridge to the device for administering somatropin.*

FDA Label Image

Htr Ifu 6mg 8 V1

Illustration showing a HUMATROPE kit with hands holding the pen-shaped device and a syringe, demonstrating its use for intramuscular or subcutaneous administration. The device is labeled with the HUMATROPE name and dosage markings, indicating how to prepare the injectable somatropin.*

FDA Label Image

Htr Ifu 6mg 9 V1

The image shows a hand removing or attaching a protective cap from the tip of a cartridge or injector pen labeled HUMATROPE, a Somatropin kit for intramuscular or subcutaneous use. The label on the cartridge indicates a strength of 6 mg and the manufacturer Eli Lilly and Company.*

FDA Label Image

Htr Ifu Case V1

The image shows a green carrying case labeled with the lightly embossed word "Lilly" on the front. This case appears to be designed for the HUMATROPE Somatropin kit, a human prescription drug for intramuscular and subcutaneous use, manufactured by Eli Lilly and Company. The case likely holds the medication and related administration supplies.*

FDA Label Image

Htr Ifu Hnc V1

HUMATROPE kit by Eli Lilly and Company shown with a cylindrical vial featuring a white label and green cap. The label includes a stylized yellow design but no further readable text. The kit is intended for intramuscular or subcutaneous use containing the active ingredient Somatropin.*

FDA Label Image

Htr Ifu Inj Sites V1

An instructional diagram showing front and back views of a human figure with highlighted injection sites for intramuscular or subcutaneous administration. Orange shaded areas indicate preferred injection locations on the abdomen, thighs, and upper arms.*

FDA Label Image

Htr Ifu Needle Parts V1

An instructional diagram showing the components of a HUMATROPE injection kit by Eli Lilly and Company. It displays the outer cap, inner cap, needle, and paper tab used for assembly or injection preparation.*

FDA Label Image

Htr Ifu Pull Tab V1

An instructional illustration showing hands removing a protective cap from a vial, likely part of the preparation process for HUMATROPE (somatropin) kit for intramuscular or subcutaneous injection.*

FDA Label Image

Htr Vl 1 V1

Packaging label images for HUMATROPE (Somatropin) kit by Eli Lilly and Company, showing three clear vials with black caps. Each vial label includes dosing and expiration information, with one label indicating the location of the expiration date. The kit is intended for intramuscular or subcutaneous administration.*

FDA Label Image

Htr Vl 10 V1

An instructional line drawing showing a person holding a syringe and vial, with one hand stabilizing the vial and the other pressing the syringe plunger downward, indicated by a downward arrow. The image depicts a step in preparing or administering an injectable medication, consistent with HUMATROPE kit usage for intramuscular or subcutaneous injection.*

FDA Label Image

Htr Vl 11 V1

An instructional illustration showing a person holding a vial labeled 'Barrel' in one hand and a syringe in the other, with an arrow indicating the syringe is being drawn upward to withdraw liquid medication from the vial. This diagram relates to the preparation of an injectable drug, possibly HUMATROPE (Somatropin).*

FDA Label Image

Htr Vl 12 V1

An instructional line drawing showing a hand holding a vial while another hand uses a syringe to withdraw liquid from the vial. This illustration is consistent with medication preparation steps, likely related to the HUMATROPE Somatropin kit for intramuscular or subcutaneous use.*

FDA Label Image

Htr Vl 13 V1

An instructional illustration showing a hand holding a vial and gently rotating it in a circular motion, indicated by a curved arrow around the vial, depicting how to mix or prepare the medication for HUMATROPE (Somatropin) kit intended for intramuscular or subcutaneous use.*

FDA Label Image

Htr Vl 14 V1

An anatomical illustration showing recommended injection sites for HUMATROPE (Somatropin) administered via intramuscular or subcutaneous routes. The front view highlights the thighs and abdominal area, while the back view indicates the buttocks and upper arms as injection locations.*

FDA Label Image

Htr Vl 15 V1

Instructional illustration showing a person lifting their shirt to expose the abdomen for an injection, demonstrating the proper site for intramuscular or subcutaneous administration of HUMATROPE (Somatropin) medication.*

FDA Label Image

Htr Vl 16 V1

A black and white line illustration showing a person pulling or adjusting the waistband of their pants. The image focuses on the torso and hand area, possibly demonstrating how to access or prepare the site for a medication injection in the abdominal region.*

FDA Label Image

Htr Vl 17 V1

An instructional illustration showing the administration of an injection into the abdominal area. A hand holds a syringe positioned for an intramuscular or subcutaneous injection, with the other hand slightly lifting the skin.*

FDA Label Image

Htr Vl 18 V1

An instructional illustration showing the proper technique for administering an injection into the abdominal area. The image depicts a hand holding a syringe positioned for subcutaneous injection just above the waistline.*

FDA Label Image

Htr Vl 2 V1

An instructional diagram illustrating the components of the HUMATROPE kit by Eli Lilly and Company. The kit includes a sharps container, a Humatrope vial with diluent, alcohol prep swabs, a cotton swab, a gauze pad, sterile needles, and sterile syringes.*

FDA Label Image

Htr Vl 3 V1

An instructional diagram showing hands holding a small vial labeled 'HUMATROPE' with a second vial positioned nearby. The image illustrates handling or preparation of the injection vials for HUMATROPE (Somatropin) kit, intended for intramuscular or subcutaneous administration.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.